Tuesday, July 28, 2020
Monday, July 27, 2020
Covid Vaccine Operation Warp Speed Press Release-Can We Use Streamlined Applied Research in Industry to Speed up Innovation?
President Trump Is Leading a Once-in-a-Generation Effort to Ensure Americans Have Access to a COVID-19 Vaccine
DEVELOPING EFFECTIVE VACCINES: President Donald J. Trump is harnessing the full power of the public and private sectors to deliver a safe and effective vaccine as soon as possible.
- The President is using all available means to ensure safe vaccines, therapeutics, and diagnostics are developed, manufactured, and distributed in unprecedented time and scale in response to COVID-19.
- Earlier this year, President Trump launched Operation Warp Speed, a groundbreaking partnership between the Federal Government, scientific community, and private sector to develop and deliver vaccines in record time.
- Operation Warp Speed’s goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021.
- The Administration has made large investments in multiple vaccine candidates to provide financial infrastructure for mass manufacturing, in parallel with late-stage clinical trials.
- Operation Warp Speed is directing a colossal industrial mobilization to ensure the rapid delivery of an eventual safe vaccine.
SEEING TREMENDOUS PROGRESS: The President’s strategy for safely expediting vaccine development is already achieving incredible results.
- There has been promising early data from clinical trials and manufacturing is ramping up as candidates go through late-stage trials.
- Operation Warp Speed has invested in more than five vaccines and teamed up with multiple pharmaceutical companies to safely produce as many effective vaccines as possible.
- A number of vaccine candidates have shown promising early clinical results and are either in or starting Phase 3 clinical trials, including AstraZeneca, Moderna, and Pfizer.
- Several vaccine candidates are using the National Institutes of Health (NIH) clinical trial network to help enroll individuals into the clinical trials.
UNLEASHING AMERICAN INGENUITY: President Trump has unleashed the power of American innovation in order to fight the invisible enemy.
- The Trump Administration is using the whole of our Nation’s scientific genius to help combat COVID-19.
- The Food and Drug Administration (FDA) has authorized more than 185 tests under emergency authorities, including more than 150 molecular tests and 30 antibody tests.
- The FDA launched its Coronavirus Treatment Acceleration Program to facilitate new treatments for COVID-19 patients as quickly as possible.
- A number of promising therapies for COVID-19, like Remdesivir, have been identified and are already in use.
Could Delta County Use "Rural Opportunities to Use Transportation for Economic Success (ROUTES) Grant?"
|Washington - U.S. Secretary of Transportation Elaine L. Chao today announced the Applicant Toolkit (Toolkit) for the Rural Opportunities to Use Transportation for Economic Success (ROUTES) Initiative at the U.S. Department of Transportation. It is the latest effort by the Department and the Trump Administration to improve rural access to federal grant funds. The Toolkit provides user-friendly information and resources to enhance rural applicants’ familiarity with the Department’s discretionary grant programs and the funding process.|
“The ROUTES Applicant Toolkit will help rural communities better identify and navigate grant funding opportunities for rural transportation projects,” said U.S. Transportation Secretary Elaine L. Chao.
Rural communities and their transportation networks have been instrumental in building and supplying urban areas throughout our nation’s history, carrying people from city to city and carrying freight from bedrock American industries such as agriculture, mining, forestry, and manufacturing. Yet rural transportation infrastructure has significant challenges.
While one-fifth of Americans live in rural areas, 70% of America’s road miles are in rural areas, carrying nearly 50% of the nation’s truck traffic. In addition, 44% of automobile travel on rural roads is done by metropolitan area citizens, and rural America’s traffic fatalities are disproportionately high, with a fatality rate twice that of urban areas. Further, of the nation’s bridges that are posted for weight limits, 90% are in rural areas.
Discretionary grant applications can be complex and resource-intensive to complete. Many of the Department’s discretionary grant programs require non-federal funding to cover a portion of project costs, which may present an additional barrier to rural communities with limited funding.
The new ROUTES Toolkit addresses these challenges by assisting rural stakeholders to better understand how to access the Department’s grants and financing products. Specifically, the Toolkit illustrates key applicant requirements when participating in the Department’s discretionary grants processes. It also catalogues discretionary grant programs by applicant type and eligible project activities. Additionally, the Toolkit provides resources for applicants to maximize the potential for award success.
Secretary Chao announced the ROUTES Initiative at the annual meeting of the American Association of State Highway Transportation Officials (AASHTO) in St. Louis, Missouri last October. The initiative is led by the ROUTES Council, an internal deliberative body at DOT, which identifies critical rural transportation concerns and coordinate efforts among the Department’s operating administrations.
To learn more about the ROUTES Initiative and the Toolkit, visit https://www.